NCT06415461View on ClinicalTrials.gov

A Study Assessing the Safety of Cord Blood Product in Sacroiliac Joint Syndrome (SIJ)

PHASE1RecruitingINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

May 10, 2024

Primary Completion Date

March 6, 2027

Study Completion Date

March 6, 2028

Conditions
Sacroiliac; BackachePain, Back
Interventions
BIOLOGICAL

PremierMaxCB®-Platinum (CFL001);

Stem Cell: Human cell, tissue, and cellular or tissue-based product (HCT/P) manufactured from umbilical cord blood

Trial Locations (1)

32610

RECRUITING

University of Florida Pain Clinic, Gainesville

All Listed Sponsors
collaborator

Cord for Life, Inc.

UNKNOWN

lead

University of Florida

OTHER